Banse Amy — SEC insider filings
SEC reporting owner CIK 1550029. 56 insider filings on record with FilingPulse; latest filed 2026-10-08.
Transaction summary — filings shown
Covers the 50 most recent of 56 filings on record, filed 2021-09-02 to 2026-10-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 8 legs across 8 filings — 5,184 shares, $697,329 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 606 shares, $333,300 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 69.
- Largest priced transaction: sale of 606 shares @ $550.00 ($333,300) in ADOBE INC., filed 2024-12-10.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| LENNAR CORP /NEW/ (LEN) | Director | 32 | 6 legs · 5,129 sh · $669,143 | — | 27 |
| ADOBE INC. (ADBE) | Director | 9 | 2 legs · 55 sh · $28,185 | 1 leg · 606 sh · $333,300 | 18 |
| CLOROX CO /DE/ (CLX) | Director | 6 | — | — | 21 |
| On Holding AG (ONON) | Director | 3 | — | — | 3 |
Insider filings — Banse Amy
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-08 | 4 | LENNAR CORP /NEW/ (LEN) | Grant/award (A): 15 @ $76.13 | EDGAR |
| 2026-09-23 | 4 | On Holding AG (ONON) | Grant/award (A): 2,433 | EDGAR |
| 2026-07-14 | 4 | LENNAR CORP /NEW/ (LEN) | Grant/award (A): 14 @ $84.27 | EDGAR |
| 2026-06-24 | 4 | On Holding AG (ONON) | Grant/award (A): 1,736 | EDGAR |
| 2026-04-24 | 4 | LENNAR CORP /NEW/ (LEN) | Grant/award (A): 12 @ $94.45 | EDGAR |
| 2026-04-17 | 4 | ADOBE INC. (ADBE) | Option exercise (M): 900 @ $0 · Option exercise (M): 900 (derivative) @ $0 · Grant/award (A): 1,367 (derivative) @ $0 | EDGAR |
| 2026-04-10 | 4 | LENNAR CORP /NEW/ (LEN) | Grant/award (A): 2,313 @ $0 | EDGAR |
| 2026-03-26 | 4 | On Holding AG (ONON) | Grant/award (A): 1,689 | EDGAR |
| 2025-12-02 | 4 | LENNAR CORP /NEW/ (LEN) | Grant/award (A): 133 @ $0 | EDGAR |
| 2025-12-01 | 4 | LENNAR CORP /NEW/ (LEN) | Other (J): 220 | EDGAR |
| 2025-09-02 | 4 | LENNAR CORP /NEW/ (LEN) | Grant/award (A): 131 @ $0 | EDGAR |
| 2025-06-03 | 4 | LENNAR CORP /NEW/ (LEN) | Grant/award (A): 164 @ $0 | EDGAR |
| 2025-04-23 | 4 | ADOBE INC. (ADBE) | Option exercise (M): 633 @ $0 · Option exercise (M): 633 (derivative) @ $0 · Grant/award (A): 900 (derivative) @ $0 | EDGAR |
| 2025-04-10 | 4 | LENNAR CORP /NEW/ (LEN) | Grant/award (A): 1,242 @ $0 | EDGAR |
| 2025-03-04 | 4 | LENNAR CORP /NEW/ (LEN) | Grant/award (A): 146 @ $0 | EDGAR |
| 2024-12-10 | 4 | ADOBE INC. (ADBE) | Sale (S): 606 @ $550 | EDGAR |
| 2024-12-02 | 4 | LENNAR CORP /NEW/ (LEN) | Grant/award (A): 100 @ $0 | EDGAR |
| 2024-10-02 | 4 | CLOROX CO /DE/ (CLX) | Grant/award (A): 161 @ $162.91 · Grant/award (A): 61.42 (derivative) @ $0 | EDGAR |
| 2024-09-03 | 4 | LENNAR CORP /NEW/ (LEN) | Grant/award (A): 96 @ $0 | EDGAR |
| 2024-07-02 | 4 | CLOROX CO /DE/ (CLX) | Grant/award (A): 192 @ $136.47 · Grant/award (A): 66.16 (derivative) @ $0 | EDGAR |
| 2024-06-03 | 4 | LENNAR CORP /NEW/ (LEN) | Grant/award (A): 109 @ $0 | EDGAR |
| 2024-04-19 | 4/A | ADOBE INC. (ADBE) | Option exercise (M): 2,035 @ $0 · Option exercise (M): 2,035 (derivative) @ $0 · Grant/award (A): 1,177 (derivative) @ $0 | EDGAR |
| 2024-04-19 | 4 | ADOBE INC. (ADBE) | Option exercise (M): 836 @ $0 · Option exercise (M): 836 (derivative) @ $0 · Grant/award (A): 633 (derivative) @ $0 | EDGAR |
| 2024-04-11 | 4 | LENNAR CORP /NEW/ (LEN) | Purchase (P): 1,575 @ $157 · Grant/award (A): 863 @ $0 | EDGAR |
| 2024-04-02 | 4 | CLOROX CO /DE/ (CLX) | Grant/award (A): 171 @ $153.11 · Grant/award (A): 61.43 (derivative) @ $0 | EDGAR |
| 2024-03-01 | 4 | LENNAR CORP /NEW/ (LEN) | Grant/award (A): 110 @ $0 | EDGAR |
| 2024-01-08 | 4 | ADOBE INC. (ADBE) | Purchase (P): 15 @ $567.03 | EDGAR |
| 2024-01-03 | 4 | CLOROX CO /DE/ (CLX) | Grant/award (A): 51.09 (derivative) @ $0 · Grant/award (A): 45.82 (derivative) @ $0 · Grant/award (A): 51.36 (derivative) @ $0 · Grant/award (A): 60.44 (derivative) @ $0 · Grant/award (A): 1,117.35 (derivative) @ $0 | EDGAR |
| 2023-12-04 | 4 | LENNAR CORP /NEW/ (LEN) | Grant/award (A): 136 @ $0 | EDGAR |
| 2023-10-16 | 4 | LENNAR CORP /NEW/ (LEN) | Purchase (P): 920 @ $108.71 | EDGAR |
| 2023-09-05 | 4 | LENNAR CORP /NEW/ (LEN) | Grant/award (A): 146 @ $0 | EDGAR |
| 2023-08-21 | 4 | LENNAR CORP /NEW/ (LEN) | Purchase (P): 859 @ $117.65 | EDGAR |
| 2023-08-16 | 4 | LENNAR CORP /NEW/ (LEN) | Purchase (P): 820 @ $123.06 | EDGAR |
| 2023-07-24 | 4 | LENNAR CORP /NEW/ (LEN) | Purchase (P): 790 @ $126.42 | EDGAR |
| 2023-06-26 | 4 | LENNAR CORP /NEW/ (LEN) | Purchase (P): 165 @ $121.29 | EDGAR |
| 2023-06-22 | 4 | ADOBE INC. (ADBE) | Purchase (P): 40 @ $492 | EDGAR |
| 2023-06-01 | 4 | LENNAR CORP /NEW/ (LEN) | Grant/award (A): 163 @ $0 | EDGAR |
| 2023-04-24 | 4 | ADOBE INC. (ADBE) | Option exercise (M): 672 @ $0 · Option exercise (M): 672 (derivative) @ $0 · Grant/award (A): 836 (derivative) @ $0 | EDGAR |
| 2023-04-13 | 4 | LENNAR CORP /NEW/ (LEN) | Grant/award (A): 1,280 @ $0 | EDGAR |
| 2023-03-01 | 4 | LENNAR CORP /NEW/ (LEN) | Grant/award (A): 180 @ $0 | EDGAR |
| 2023-01-04 | 4 | CLOROX CO /DE/ (CLX) | Grant/award (A): 42.48 (derivative) @ $0 · Grant/award (A): 38.97 (derivative) @ $0 · Grant/award (A): 43.18 (derivative) @ $0 · Grant/award (A): 44.25 (derivative) @ $0 · Grant/award (A): 1,073.32 (derivative) @ $0 | EDGAR |
| 2022-12-01 | 4 | LENNAR CORP /NEW/ (LEN) | Grant/award (A): 199 @ $0 | EDGAR |
| 2022-09-01 | 4 | LENNAR CORP /NEW/ (LEN) | Grant/award (A): 225 @ $0 | EDGAR |
| 2022-06-01 | 4 | LENNAR CORP /NEW/ (LEN) | Grant/award (A): 218 @ $0 | EDGAR |
| 2022-04-18 | 4 | ADOBE INC. (ADBE) | Option exercise (M): 615 @ $0 · Option exercise (M): 615 (derivative) @ $0 · Grant/award (A): 672 (derivative) @ $0 | EDGAR |
| 2022-04-14 | 4 | LENNAR CORP /NEW/ (LEN) | Grant/award (A): 1,764 @ $0 | EDGAR |
| 2022-03-01 | 4 | LENNAR CORP /NEW/ (LEN) | Grant/award (A): 194 @ $0 | EDGAR |
| 2022-01-04 | 4 | CLOROX CO /DE/ (CLX) | Grant/award (A): 25.33 (derivative) @ $0 · Grant/award (A): 25.90 (derivative) @ $0 · Grant/award (A): 29.58 (derivative) @ $0 · Grant/award (A): 30.33 (derivative) @ $0 · Grant/award (A): 918.60 (derivative) @ $0 | EDGAR |
| 2021-12-01 | 4 | LENNAR CORP /NEW/ (LEN) | Grant/award (A): 166 @ $0 | EDGAR |
| 2021-09-02 | 4 | LENNAR CORP /NEW/ (LEN) | Grant/award (A): 163 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-01-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1550029 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs